Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Rutgeerts

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Strategies in the prevention of post-operative recurrence in Crohn's diseasePaul Rutgeerts
Journal of Gastroenterology and Hepatology|May 10, 2002
A critical assessment of new therapies in inflammatory bowel diseasePaul Rutgeerts
Digestive Diseases (Basel, Switzerland)|July 17, 2012
How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?Paul Rutgeerts
Immunotherapy|November 8, 2011
Cytokine blockade in inflammatory bowel diseasesClémentine Perrier, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)|October 19, 2012
New drug therapies on the horizon for IBDClémentine Perrier, Paul Rutgeerts
Inflammatory Bowel Diseases|July 29, 2009
Importance of mucosal healing in ulcerative colitisGary R Lichtenstein, Paul Rutgeerts
Gastroenterology Clinics of North America|June 5, 2004
Medical management of postoperative recurrence in Crohn's diseaseGert Van Assche, Paul Rutgeerts
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 14, 2005
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel diseaseGert Van Assche, Paul Rutgeerts
Inflammatory Bowel Diseases|July 20, 2002
Antiadhesion molecule therapy in inflammatory bowel diseaseGert van Assche, Paul Rutgeerts
Gut|September 17, 2013
Recent advances: Personalised use of current Crohn's disease therapeutic optionsSéverine Vermeire, Marc Ferrante, Paul Rutgeerts
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Strategies in the prevention of post-operative recurrence in Crohn's diseasePaul Rutgeerts
Journal of Gastroenterology and Hepatology|May 10, 2002
A critical assessment of new therapies in inflammatory bowel diseasePaul Rutgeerts
Digestive Diseases (Basel, Switzerland)|July 17, 2012
How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?Paul Rutgeerts
Immunotherapy|November 8, 2011
Cytokine blockade in inflammatory bowel diseasesClémentine Perrier, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)|October 19, 2012
New drug therapies on the horizon for IBDClémentine Perrier, Paul Rutgeerts
Inflammatory Bowel Diseases|July 29, 2009
Importance of mucosal healing in ulcerative colitisGary R Lichtenstein, Paul Rutgeerts
Gastroenterology Clinics of North America|June 5, 2004
Medical management of postoperative recurrence in Crohn's diseaseGert Van Assche, Paul Rutgeerts
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 14, 2005
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel diseaseGert Van Assche, Paul Rutgeerts
Inflammatory Bowel Diseases|July 20, 2002
Antiadhesion molecule therapy in inflammatory bowel diseaseGert van Assche, Paul Rutgeerts
Gut|September 17, 2013
Recent advances: Personalised use of current Crohn's disease therapeutic optionsSéverine Vermeire, Marc Ferrante, Paul Rutgeerts
Pageof 32